eXoZymes, Inc.
NASDAQ:EXOZBiotechnology
+$1.06 today
- Market cap
- $51.42M
- Beta
- 2.66
- P/E (TTM)
- -6.5
- EPS (TTM)
- -$1.14
Volume 0.01M
Average 0.01M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
eXoZymes, Inc.
NASDAQ:EXOZ
Intrinsic Alpha fair value
Locked
Current Price
$5.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A — |
| Revenue | N/A | N/A | N/A | N/A — |
| Net Income | N/A | N/A | N/A | N/A — |
| EBIT | N/A | N/A | N/A | N/A — |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
Greenwich LifeSciences, Inc. NASDAQ:GLSI | $267.44M | $18.22 | Not rated | -15.6 | +142.52% |
Surrozen, Inc. NASDAQ:SRZN | $220.88M | $29.54 | Not rated | -0.7 | +123.22% |
Cognition Therapeutics, Inc. NASDAQ:CGTX | $83.81M | $0.94 | Not rated | -6.4 | -54.84% |
Oncolytics Biotech Inc. NASDAQ:ONCY | $68.58M | $0.68 | Not rated | -4.3 | -49.34% |
Tiziana Life Sciences Ltd NASDAQ:TLSA | $64.27M | $1.01 | Not rated | -4.0 | -58.30% |
Instil Bio, Inc. NASDAQ:TIL | $48.63M | $7.17 | Not rated | -1.1 | -37.76% |
Continue the stock analysis
Jump to another research area for this company.